Ahrek, Bill is going to shove your ridiculous conc
Post# of 379

Quote:
Ahrek, Bill is going to shove your ridiculous conclusions right down your throat. Mark my words.
https://www.sec.gov/Archives/edgar/data/16538...31_10k.htm
On September 12, 2016, the Company completed the transaction to acquire assets, including patented Cold LED Lighting Technology, from Tesla Digital, Inc. (A Canadian Corporation) and Stevan (Steve) Pokrajac.
The material consideration given by Company includes:
(a)3,125,000 shares of Cen Biotech stock. The issuance is to be completed, at the Company discretion, within no more than 180 days from the closing date.
(b)
The transfer of real properties located at 135 North Rear Road having a book value of $2,161,467 USD and 1517-1525 Ridge Road having a purchase cost (including other related disbursements) to the Company of approximately $182,488.
The Company’s fixed assets consist of the following: a property at 135 North Rear Road, and leasehold improvements at 20 North Rear Road. The company paid $1,064,651 in order to buy 135 North Rear Road, which is intended to serve as an office and an experimental growing space for the Company. This amount was capitalized as an asset in the balance sheet called “land.” All of these assets were acquired during 2014. In September 2016, the property at 135 North Rear Road was included in the deal to acquire a technology patent – see Note 12 for details.
The Company leases 20 North Rear Road from a cousin of Mr. Chaaban, the Company’s President (see note

Leasehold improvements $ 6,105,711
Accumulated impairment $4,835,596
Net Leasehold Improvements $1,270,115

